Search - tctmd.com

Displaying 541 - 560 of 719

Sort: Relevancy | Date

News Daily News

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

L.A. McKeown

March 28, 2018

News Daily News

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

Michael O'Riordan

March 27, 2018

News Conference News ACC 2018

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Shelley Wood

March 27, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Daily News

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Yael L. Maxwell

March 26, 2018

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Daily News

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

Todd Neale

March 23, 2018

Presentation CIT 2018

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

Presenter: Ran Kornowski

March 23, 2018

News Daily News

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

L.A. McKeown

March 21, 2018

News Daily News

‘Practical Guide’ for NOACs Gets an Update

Todd Neale

March 20, 2018

News Daily News

ESC Releases New Syncope Guidelines

Shelley Wood

March 20, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Michael O'Riordan

March 16, 2018

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Shelley Wood

March 16, 2018

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

Advertisement

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR

My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

Optimal Pharmacology and PCI Strategy in STEMI & Multivessel Disease

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

‘Practical Guide’ for NOACs Gets an Update

ESC Releases New Syncope Guidelines

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content